Marfan syndrome. Part 2: Treatment and management of patients

Nature Reviews Cardiology

Volumn 7, Issue 5, 2010, Pages 266-276

  Cãadas, Victoria ^a   Vilacosta, Isidre ^a   Bruna, Isidoro ^b   Fuster, Valentin ^c  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Hospital Madrid Monteprincipe   (Spain)

^c MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYCYCLINE; ENALAPRIL; HEPARIN; LOSARTAN; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; PLACEBO; PROPRANOLOL; TRANSFORMING GROWTH FACTOR BETA; VERAPAMIL;

ABDOMINAL AORTA ANEURYSM; AORTA DILATATION; AORTA DISEASE; AORTA DISSECTION; AORTA RECONSTRUCTION; AORTA RUPTURE; AORTA VALVE REGURGITATION; AORTIC ROOT SURGERY; ARTERIAL STIFFNESS; BRONCHOSPASM; CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; ENDOCARDITIS; FETUS DEATH; GENETIC COUNSELING; HEART VALVE PROSTHESIS; HUMAN; INFECTION; LIFESTYLE MODIFICATION; MARFAN SYNDROME; MATERNAL MORTALITY; MITRAL VALVE PROLAPSE; NONHUMAN; PATIENT MONITORING; POSTPARTUM HEMORRHAGE; PREMATURE LABOR; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SOMNOLENCE; SPONTANEOUS ABORTION; SURGICAL TECHNIQUE; THIRD TRIMESTER PREGNANCY; THORACIC AORTA ANEURYSM; UTERINE CERVIX INCOMPETENCE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AORTIC ANEURYSM, THORACIC; BLOOD VESSEL PROSTHESIS IMPLANTATION; COHORT STUDIES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MARFAN SYNDROME; MICE; MITRAL VALVE PROLAPSE; MONITORING, PHYSIOLOGIC; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77951765878     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2010.31     Document Type: Review

References (78)

1. Milewicz, D. M., Dietz, H. C. & Miller, D. C. Treatment of aortic disease in patients with Marfan syndrome. Circulation 111, e150-e157 (2005).
2. engelfriet, P. M., Boersma, e., Tijssen, J. G., Bouma, B. J. & Mulder, B. J. Beyond the root: dilatation of the distal aorta in Marfan's syndrome. Heart 92, 1238-1243 (2006).
3. Cañadas, V., Vilacosta, I., Bruna, I. & Fuster, V. Marfan syndrome. Part 1: pathophysiology and diagnosis. Nat. Rev. Cardiol. doi:10.1038/ nrcardio.2010.30
4. Murdoch, J. L., Walker, B. A., Halpern, B. L., Kuzma, J. W. & McKusick, V. A. Life expectancy and causes of death in the Marfan syndrome. N. Engl. J. Med. 286, 804-808 (1972).
5. Finkbohner, r., Johnston, D., Crawford, e. S., Coselli, J. & Milewicz, D. M. Marfan syndrome. Long-term survival and complications after aortic aneurysm repair. Circulation 91, 728-733 (1995).
6. Silverman, D. I. et al. Life expectancy in the Marfan syndrome. Am. J. Cardiol. 75, 157-160 (1995).
7. Gott, V. L., Pyeritz, r. e., Cameron, D. e., Greene, P. S. & McKusick, V. A. Composite graft repair of Marfan aneurysm of the ascending aorta: results in 100 patients. Ann. Thorac. Surg. 52, 38-44 (1991).
8. Gersony, D. r., McClaughlin, M. A., Jin, Z. & Gersony, W. M. The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis. Int. J. Cardiol. 114, 303-308 (2007).
9. Halpern, B. L., Char, F., Murdoch, J. L., Horton, W. B. & McKusick, V. A. A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment. Johns Hopkins Med. J. 129, 123-129 (1971).
10. Ladouceur, M. et al. effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome. Am. J. Cardiol. 99, 406-409 (2007).
11. rossi-Foulkes, r. et al. Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. Am. J. Cardiol. 83, 1364-1368 (1999).
12. Salim, M. A., Alpert, B. S., Ward, J. C. & Pyeritz, r. e. effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome. Am. J. Cardiol. 74, 629-633 (1994).
13. Selamet Tierney, e. S. et al. Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome. J. Pediatr. 150, 77-82 (2007).
14. Shores, J., Berger, K. r., Murphy, e. A. & Pyeritz, r. e. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N. Engl. J. Med. 330, 1335-1341 (1994).
15. Yetman, A. T., Bornemeier, r. A. & McCrindle, B. W. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am. J. Cardiol. 95, 1125-1127 (2005).
16. Haouzi, A., Berglund, H., Pelikan, P. C., Maurer, G. & Siegel, r. J. Heterogeneous aortic response to acute beta-adrenergic blockade in Marfan syndrome. Am. Heart J. 133, 60-63 (1997).
17. Nollen, G. J. et al. Aortic pressure-area relation in Marfan patients with and without beta blocking agents: a new non-invasive approach. Heart 90, 314-318 (2004).
18. reed, C. M., Fox, M. e. & Alpert, B. S. Aortic biomechanical properties in pediatric patients with the Marfan syndrome, and the effects of atenolol. Am. J. Cardiol. 71, 606-608 (1993).
19. rios, A. S. et al. effect of long-term betablockade on aortic root compliance in patients with Marfan syndrome. Am. Heart J. 137, 1057-1061 (1999).
20. Dean, J. C. S. Marfan syndrome: clinical diagnosis and management. Eur. J. Hum. Genet. 15, 724-733 (2007).
21. Cameron, D. e. et al. Aortic root replacement in 372 Marfan patients: evolution of operative repair over 30 years. Ann. Thorac. Surg. 87, 1344-1349 (2009).
22. Keane, M. G. & Pyeritz, r. e. Medical management of Marfan syndrome. Circulation 117, 2802-2813 (2008).
23. Ahimastos, A. A. et al. effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA 298, 1539-1547 (2007).
24. Brooke, B. S. et al. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N. Engl. J. Med. 358, 2787-2795 (2008).
25. Habashi, J. P. et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312, 117-121 (2006).
26. Matt, P. et al. recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J. Thorac. Cardiovasc. Surg. 135, 389-394 (2008).
27. Stroth, U. & Unger, T. The renin-angiotensin system and its receptors. J. Cardiovasc. Pharmacol. 33 (Suppl. 1), S21-S28 (1999).
28. Nagashima, H. et al. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome. Circulation 104, I282-I287 (2001).
29. Neptune, e. r. et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33, 407-411 (2003).
30. Ng, C. M. et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J. Clin. Invest. 114, 1586-1592 (2004).
31. Xiong, W., Knispel, r. A., Dietz, H. C., ramirez, F. & Baxter, B. T. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome. J. Vasc. Surg. 47, 166-172 (2008).
32. Chung, A. W., Yang, H. H., radomski, M. W. & van Breemen, C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ. Res. 102, e73-e85 (2008).
33. Abdul-Hussien, H. et al. Doxycycline therapy for abdominal aneurysm: improved proteolytic balance through reduced neutrophil content. J. Vasc. Surg. 49, 741-749 (2009).
34. Lindeman, J. H., Abdul-Hussien, H., van Bockel, J. H., Wolterbeek, r. & Kleemann, r. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 119, 2209-2216 (2009).
35. Gott, V. L. et al. replacement of the aortic root in patients with Marfan's syndrome. N. Engl. J. Med. 340, 1307-1313 (1999).
36. Pearson, G. D. et al. report of the National Heart, Lung and Blood Institute and National Marfan Foundation Working Group on research in Marfan Syndrome and related Disorders. Circulation 118, 785-791 (2008).
37. Vahanian, A. et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the european Society of Cardiology. Eur. Heart J. 28, 230-268 (2007).
38. Vricella, L. A. et al. early experience with valvesparing aortic root replacement in children. Ann. Thorac. Surg. 80, 1622-1626 (2005).
39. everitt, M. D. et al. Cardiovascular surgery in children with Marfan syndrome or Loeys-Dietz syndrome. J. Thorac. Cardiovasc. Surg. 137, 1327-1332 (2009).
40. Patel, N. D. et al. Aortic root operations for Marfan syndrome: a comparison of the Bentall and valve-sparing procedures. Ann. Thorac. Surg. 85, 2003-2010 (2008).
41. Volguina, I. V. et al. Valve-sparing and valvereplacing techniques for aortic root replacement in patients with Marfan syndrome: analysis of early outcome. J. Thorac. Cardiovasc. Surg. 137, 1124-1132 (2009).
42. Hilgenberg, A. D. & Mora, B. N. Composite aortic root replacement with a bovine pericardial valve conduit. Ann. Thorac. Surg. 75, 1338-1339 (2003).
43. David, T. e., Armstrong, S., Maganti, M., Colman, J. & Bradley, T. J. Long-term results of aortic valve-sparing operations in patients with Marfan syndrome. J. Thorac. Cardiovasc. Surg. 138, 859-864 (2009).
44. erasmi, A. W. et al. remodeling or reimplantation for valve-sparing aortic root surgery? Ann. Thorac. Surg. 83, S752-S756 (2007).
45. Kallenbach, K. et al. Aortic valve-sparing operation in Marfan syndrome: what do we know after a decade? Ann. Thorac. Surg. 83, S764-S768 (2007).
46. David, T. e. & Feindel, C. M. An aortic valvesparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J. Thorac. Cardiovasc. Surg. 103, 617-621 (1992).
47. Sarsam, M. A. & Yacoub, M. remodeling of the aortic valve anulus. J. Thorac. Cardiovasc. Surg. 105, 435-438 (1993).
48. David, T. e. et al. Aortic valve preservation in patients with aortic root aneurysm: results of the reimplantation technique. Ann. Thorac. Surg. 83, S732-S735 (2007).
49. Lansac, e. et al. external aortic annuloplasty ring for valve-sparing procedures. Ann. Thorac. Surg. 79, 356-358 (2005).
50. Meijboom, L. J. et al. Frequency of coronary ostial aneurysms after aortic root surgery in patients with the Marfan syndrome. Am. J. Cardiol. 89, 1135-1138 (2002).
51. Svensson, L. G. et al. expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann. Thorac. Surg. 85, S1-S41 (2008).
52. erbel, r. Diseases of the thoracic aorta. Heart 86, 227-234 (2001).
53. LeMaire, S. A. et al. Spectrum of aortic operations in 300 patients with confirmed or suspected Marfan syndrome. Ann. Thorac. Surg. 81, 2063-2078 (2006).
54. Girdauskas, e., Kuntze, T., Borger, M. A., Falk, V. & Mohr, F. W. Distal aortic reinterventions after root surgery in Marfan patients. Ann. Thorac. Surg. 86, 1815-1819 (2008).
55. Nordon, I. M. et al. endovascular management of chronic aortic dissection in patients with Marfan syndrome. J. Vasc. Surg. 50, 987-991 (2009).
56. Botta, L. et al. Stent graft repair of descending aortic dissection in patients with Marfan syndrome: an effective alternative to open reoperation? J. Thorac. Cardiovasc. Surg. 138, 1108-1114 (2009).
57. Maron, B. J. et al. recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 109, 2807-2816 (2004).
58. Judge, D. P. & Dietz, H. C. Marfan's syndrome. Lancet 366, 1965-1976 (2005).
59. Bhudia, S. K. et al. Mitral valve surgery in the adult Marfan syndrome patient. Ann. Thorac. Surg. 81, 843-848 (2006).
60. Fuzellier, J. F. et al. Surgical management of mitral regurgitation associated with Marfan's syndrome. Ann. Thorac. Surg. 66, 68-72 (1998).
61. Gillinov, A. M. et al. Mitral valve operation in patients with the Marfan syndrome. J. Thorac. Cardiovasc. Surg. 107, 724-731 (1994).
62. Wilson, W. et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association rheumatic Fever, endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes research Interdisciplinary Working Group. Circulation 116, 1736-1754 (2007).
63. National Marfan Foundation NMF PAB Endocarditis Prophylaxis Guidelines, 2007 [online], http://www.marfan.org/marfan/2565/ NMF-PAB-endocarditis- Prophylaxis- Guidelines--2007 (2007).
64. Lalchandani, S. & Wingfield, M. Pregnancy in women with Marfan's syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 110, 125-130 (2003).
65. Lledo, B., Ten, J., Galan, F. M. & Bernabeu, r. Preimplantation genetic diagnosis of Marfan syndrome using multiple displacement amplification. Fertil. Steril. 86, 949-955 (2006).
66. Immer, F. F. et al. Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann. Thorac. Surg. 76, 309-314 (2003).
67. Meijboom, L. J. et al. Obstetric complications in Marfan syndrome. Int. J. Cardiol. 110, 53-59 (2006).
68. Bonow, r. O. et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114, e84-e231 (2006).
69. Pacini, L. et al. Maternal complication of pregnancy in Marfan syndrome. Int. J. Cardiol. 136, 156-161 (2008).
70. Meijboom, L. J. et al. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur. Heart J. 26, 914-920 (2005).
71. Pyeritz, r. e. Maternal and fetal complications of pregnancy in the Marfan syndrome. Am. J. Med. 71, 784-790 (1981).
72. Lipscomb, K. J., Smith, J. C., Clarke, B., Donnai, P. & Harris, r. Outcome of pregnancy in women with Marfan's syndrome. Br. J. Obstet. Gynaecol. 104, 201-206 (1997).
73. rossiter, J. P., repke, J. T., Morales, A. J., Murphy, e. A. & Pyeritz, r. e. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am. J. Obstet. Gynecol. 173, 1599-1606 (1995).
74. Bates, S. M., Greer, I. A., Hirsh, J. & Ginsberg, J. S. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126, 627S-644S (2004). (Pubitemid 39297966)
75. Hirsh, J., Fuster, V., Ansell, J. & Halperin, J. L. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 107, 1692-1711 (2003). (Pubitemid 36397341)
76. Altman, r. et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J. Thorac. Cardiovasc. Surg. 101, 427-431 (1991).
77. Hanania, G. Management of anticoagulants during pregnancy. Heart 86, 125-126 (2001).
78. Sbarouni, e. & Oakley, C. M. Outcome of pregnancy in women with valve prostheses. Br. Heart J. 71, 196-201 (1994).